|  Help  |  About  |  Contact Us

Publication : Genetic evidence that SOST inhibits WNT signaling in the limb.

First Author  Collette NM Year  2010
Journal  Dev Biol Volume  342
Issue  2 Pages  169-79
PubMed ID  20359476 Mgi Jnum  J:161416
Mgi Id  MGI:4458999 Doi  10.1016/j.ydbio.2010.03.021
Citation  Collette NM, et al. (2010) Genetic evidence that SOST inhibits WNT signaling in the limb. Dev Biol 342(2):169-79
abstractText  SOST is a negative regulator of bone formation, and mutations in human SOST are responsible for sclerosteosis. In addition to high bone mass, sclerosteosis patients occasionally display hand defects, suggesting that SOST may function embryonically. Here we report that overexpression of SOST leads to loss of posterior structures of the zeugopod and autopod by perturbing anterior-posterior and proximal-distal signaling centers in the developing limb. Mutant mice that overexpress SOST in combination with Grem1 and Lrp6 mutations display more severe limb defects than single mutants alone, while Sost(-/-) significantly rescues the Lrp6(-/-) skeletal phenotype, signifying that SOST gain-of-function impairs limb patterning by inhibiting the WNT signaling through LRP5/6.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

56 Bio Entities

0 Expression